March 4 (Reuters) - BioCryst Pharmaceuticals Inc BCRX.O:
BIOCRYST PHARMACEUTICALS INC - CFO ANTHONY DOYLE TO RESIGN EFFECTIVE APRIL 9, 2025
Source text: [ID:n0001171843-25-001231]
Further company coverage: BCRX.O
(Reuters.Briefs@thomsonreuters.com)
March 4 (Reuters) - BioCryst Pharmaceuticals Inc BCRX.O:
BIOCRYST PHARMACEUTICALS INC - CFO ANTHONY DOYLE TO RESIGN EFFECTIVE APRIL 9, 2025
Source text: [ID:n0001171843-25-001231]
Further company coverage: BCRX.O
(Reuters.Briefs@thomsonreuters.com)
Comments